Andy Lundin, Author at Hematology Advancements

The Intersection of AI and Wearable Tech in Blood Health Monitoring

Posted by Andy Lundin | Jun 11, 2024 | Technology |

AI-enhanced wearable technologies are revolutionizing blood health monitoring by continuously tracking vital health metrics.

Posted by Andy Lundin | Jun 11, 2024 | Regulatory Impact |

Recent FDA approvals of innovative therapies are transforming blood cancer treatment and improving patient outcomes.

Biopharmaceuticals, including monoclonal antibodies, targeted therapies, and CAR T-cell therapy, are transforming treatment of blood cancers.

Posted by Andy Lundin | Jun 7, 2024 | Diagnostic Tools |

Discover how liquid biopsies offer a non-invasive, effective approach for diagnosing and monitoring blood cancers.

Posted by Andy Lundin | Jun 7, 2024 | Research Updates |

Genetic engineering is revolutionizing hematopoietic stem cell transplantation, enhancing antitumor efficacy, and reducing complications.